NIAGEN BIOSCIENCE INC (NAGE) Forecast, Price Target & Analyst Ratings

NASDAQ:NAGE • US1710774076

Current stock price

4.695 USD
+0.04 (+0.75%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NIAGEN BIOSCIENCE INC (NAGE).

Forecast Snapshot

Consensus Price Target

Price Target
$16.12
+ 243.26% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.07
Revenue Estimate
30.879M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.45%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.12
Upside
+ 243.26%
From current price of $4.70 to mean target of $16.12, Based on 11 analyst forecasts
Low
$12.12
Median
$14.28
High
$24.15

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for NAGE. The average price target is 16.12 USD. This implies a price increase of 243.26% is expected in the next year compared to the current price of 4.695.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NAGE Current Analyst RatingNAGE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

NAGE Historical Analyst RatingsNAGE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.45%
NAGE was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NAGE.
In the previous month the buy percentage consensus was at a similar level.
NAGE was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05Canaccord GenuityMaintains Buy -> Buy
2025-11-05Canaccord GenuityMaintains Buy -> Buy
2025-08-11HC Wainwright & Co.Maintains Buy -> Buy
2025-06-10Canaccord GenuityMaintains Buy -> Buy
2025-06-06Roth CapitalMaintains Buy -> Buy
2025-05-27Canaccord GenuityInitiate Buy
2025-04-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-31HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.07
Revenue Estimate
30.879M
Revenue Q2Q
1.31%
EPS Q2Q
19.00%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
-14.58%
Revenue (3 Months)
-14.58%
EPS (1 Month)
31.26%
EPS (3 Months)
31.26%

Next Earnings Summary

NAGE is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.07 USD and the consensus revenue estimate is 30.88M USD.
The next earnings revenue estimate has been revised downward by 14.58% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
NAGE revenue by date.NAGE revenue by date.
83.57M
15.99%		99.597M
19.18%		129.423M
29.95%		150.79M
16.51%		172.77M
14.58%		214.24M
24.00%
EBITDA
YoY % growth
NAGE ebitda by date.NAGE ebitda by date.
-4.571M
73.98%		8.54M
286.83%		15.081M
76.59%		28.135M
86.56%		39.78M
41.39%		N/A
EBIT
YoY % growth
NAGE ebit by date.NAGE ebit by date.
-5.599M
69.95%		7.726M
237.99%		14.296M
85.04%		18.007M
25.96%		27.252M
51.34%		41.351M
51.74%
Operating Margin
NAGE operating margin by date.NAGE operating margin by date.
-6.70%7.76%11.05%11.94%15.77%19.30%
EPS
YoY % growth
NAGE eps by date.NAGE eps by date.
-0.07
73.08%		0.10
242.86%		0.18
80.00%		0.30
67.17%		0.45
49.15%		0.64
43.18%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.07
19.00%		0.07
78.50%		0.08
69.99%		0.07
149.32%		0.10
42.86%		0.11
50.00%		0.13
56.01%		0.09
15.91%
Revenue
Q2Q % growth		30.879M
1.31%		38.284M
23.03%		41.313M
21.56%		40.708M
20.30%		44.426M
43.87%		45.834M
19.72%		50.113M
21.30%		47.144M
15.81%
EBITDA
Q2Q % growth		7.337M
47.71%		6.661M
86.27%		8.364M
73.45%		5.809M
101.14%		9.588M
30.68%		10.098M
51.60%		11.628M
39.02%		8.466M
45.74%
EBIT
Q2Q % growth		2.76M
-42.16%		4.672M
46.69%		6.095M
43.89%		3.514M
67.09%		7.41M
168.48%		7.742M
65.71%		9.481M
55.55%		6.355M
80.85%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NAGE Yearly Revenue VS EstimatesNAGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
NAGE Yearly EPS VS EstimatesNAGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
52.84%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
18.17%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NIAGEN BIOSCIENCE INC / NAGE Forecast FAQ

Can you provide the average price target for NIAGEN BIOSCIENCE INC stock?

11 analysts have analysed NAGE and the average price target is 16.12 USD. This implies a price increase of 243.26% is expected in the next year compared to the current price of 4.695.

Can you provide the upcoming earnings date for NIAGEN BIOSCIENCE INC?

NIAGEN BIOSCIENCE INC (NAGE) will report earnings on 2026-05-05.

Can you provide the consensus estimates for NIAGEN BIOSCIENCE INC next earnings?

The consensus EPS estimate for the next earnings of NIAGEN BIOSCIENCE INC (NAGE) is 0.07 USD and the consensus revenue estimate is 30.88M USD.

How many analysts cover NIAGEN BIOSCIENCE INC (NAGE) stock?

The number of analysts covering NIAGEN BIOSCIENCE INC (NAGE) is 11.